nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—semen—cervical cancer	0.0583	0.306	CbGeAlD
Bicalutamide—Febrile neutropenia—Topotecan—cervical cancer	0.0373	0.046	CcSEcCtD
Bicalutamide—Pelvic pain—Topotecan—cervical cancer	0.0369	0.0455	CcSEcCtD
Bicalutamide—Intestinal obstruction—Topotecan—cervical cancer	0.0329	0.0406	CcSEcCtD
Bicalutamide—Interstitial lung disease—Topotecan—cervical cancer	0.0317	0.0391	CcSEcCtD
Bicalutamide—Lung disorder—Topotecan—cervical cancer	0.0317	0.0391	CcSEcCtD
Bicalutamide—Pleural effusion—Topotecan—cervical cancer	0.0293	0.0362	CcSEcCtD
Bicalutamide—Blood bilirubin increased—Topotecan—cervical cancer	0.0237	0.0293	CcSEcCtD
Bicalutamide—Bone pain—Topotecan—cervical cancer	0.0234	0.0289	CcSEcCtD
Bicalutamide—Neuropathy—Topotecan—cervical cancer	0.021	0.026	CcSEcCtD
Bicalutamide—Neoplasm—Topotecan—cervical cancer	0.0203	0.025	CcSEcCtD
Bicalutamide—Sepsis—Topotecan—cervical cancer	0.0195	0.024	CcSEcCtD
Bicalutamide—Cardiac arrest—Topotecan—cervical cancer	0.0155	0.0191	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0147	0.0181	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0144	0.0177	CcSEcCtD
Bicalutamide—Neutropenia—Topotecan—cervical cancer	0.0132	0.0163	CcSEcCtD
Bicalutamide—Weight increased—Topotecan—cervical cancer	0.0128	0.0158	CcSEcCtD
Bicalutamide—Pneumonia—Topotecan—cervical cancer	0.0126	0.0156	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Topotecan—cervical cancer	0.0123	0.0152	CcSEcCtD
Bicalutamide—Sweating—Topotecan—cervical cancer	0.012	0.0149	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Topotecan—cervical cancer	0.0119	0.0147	CcSEcCtD
Bicalutamide—Epistaxis—Topotecan—cervical cancer	0.0118	0.0146	CcSEcCtD
Bicalutamide—Haemoglobin—Topotecan—cervical cancer	0.0113	0.014	CcSEcCtD
Bicalutamide—Rhinitis—Topotecan—cervical cancer	0.0113	0.0139	CcSEcCtD
Bicalutamide—Haemorrhage—Topotecan—cervical cancer	0.0113	0.0139	CcSEcCtD
Bicalutamide—Pharyngitis—Topotecan—cervical cancer	0.0112	0.0138	CcSEcCtD
Bicalutamide—AR—epithelium—cervical cancer	0.0107	0.0564	CbGeAlD
Bicalutamide—AR—uterine cervix—cervical cancer	0.0107	0.0559	CbGeAlD
Bicalutamide—Angiopathy—Topotecan—cervical cancer	0.0102	0.0126	CcSEcCtD
Bicalutamide—Immune system disorder—Topotecan—cervical cancer	0.0102	0.0126	CcSEcCtD
Bicalutamide—AR—decidua—cervical cancer	0.0101	0.0532	CbGeAlD
Bicalutamide—Mediastinal disorder—Topotecan—cervical cancer	0.0101	0.0125	CcSEcCtD
Bicalutamide—Chills—Topotecan—cervical cancer	0.0101	0.0125	CcSEcCtD
Bicalutamide—AR—renal system—cervical cancer	0.00996	0.0523	CbGeAlD
Bicalutamide—Alopecia—Topotecan—cervical cancer	0.00995	0.0123	CcSEcCtD
Bicalutamide—Malnutrition—Topotecan—cervical cancer	0.0098	0.0121	CcSEcCtD
Bicalutamide—AR—endometrium—cervical cancer	0.00963	0.0505	CbGeAlD
Bicalutamide—Back pain—Topotecan—cervical cancer	0.00948	0.0117	CcSEcCtD
Bicalutamide—Muscle spasms—Topotecan—cervical cancer	0.00942	0.0116	CcSEcCtD
Bicalutamide—AR—mammalian vulva—cervical cancer	0.00932	0.0489	CbGeAlD
Bicalutamide—Anaemia—Topotecan—cervical cancer	0.00906	0.0112	CcSEcCtD
Bicalutamide—Angioedema—Topotecan—cervical cancer	0.00896	0.0111	CcSEcCtD
Bicalutamide—AR—uterus—cervical cancer	0.00888	0.0466	CbGeAlD
Bicalutamide—Cough—Topotecan—cervical cancer	0.00855	0.0106	CcSEcCtD
Bicalutamide—Myalgia—Topotecan—cervical cancer	0.00834	0.0103	CcSEcCtD
Bicalutamide—Chest pain—Topotecan—cervical cancer	0.00834	0.0103	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00829	0.0102	CcSEcCtD
Bicalutamide—AR—female reproductive system—cervical cancer	0.00798	0.0419	CbGeAlD
Bicalutamide—Infection—Topotecan—cervical cancer	0.00795	0.00982	CcSEcCtD
Bicalutamide—Nervous system disorder—Topotecan—cervical cancer	0.00784	0.00969	CcSEcCtD
Bicalutamide—Thrombocytopenia—Topotecan—cervical cancer	0.00783	0.00968	CcSEcCtD
Bicalutamide—Skin disorder—Topotecan—cervical cancer	0.00777	0.0096	CcSEcCtD
Bicalutamide—Hyperhidrosis—Topotecan—cervical cancer	0.00773	0.00955	CcSEcCtD
Bicalutamide—Anorexia—Topotecan—cervical cancer	0.00762	0.00942	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00729	0.009	CcSEcCtD
Bicalutamide—AR—female gonad—cervical cancer	0.00726	0.0381	CbGeAlD
Bicalutamide—AR—vagina—cervical cancer	0.00722	0.0379	CbGeAlD
Bicalutamide—Paraesthesia—Topotecan—cervical cancer	0.00718	0.00887	CcSEcCtD
Bicalutamide—Dyspnoea—Topotecan—cervical cancer	0.00713	0.00881	CcSEcCtD
Bicalutamide—Dyspepsia—Topotecan—cervical cancer	0.00704	0.0087	CcSEcCtD
Bicalutamide—Decreased appetite—Topotecan—cervical cancer	0.00695	0.00859	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Topotecan—cervical cancer	0.00691	0.00853	CcSEcCtD
Bicalutamide—Fatigue—Topotecan—cervical cancer	0.0069	0.00852	CcSEcCtD
Bicalutamide—Pain—Topotecan—cervical cancer	0.00684	0.00845	CcSEcCtD
Bicalutamide—Constipation—Topotecan—cervical cancer	0.00684	0.00845	CcSEcCtD
Bicalutamide—CYP2C19—vagina—cervical cancer	0.00669	0.0351	CbGeAlD
Bicalutamide—Feeling abnormal—Topotecan—cervical cancer	0.00659	0.00814	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Topotecan—cervical cancer	0.00654	0.00808	CcSEcCtD
Bicalutamide—Urticaria—Topotecan—cervical cancer	0.00635	0.00785	CcSEcCtD
Bicalutamide—Abdominal pain—Topotecan—cervical cancer	0.00632	0.00781	CcSEcCtD
Bicalutamide—Body temperature increased—Topotecan—cervical cancer	0.00632	0.00781	CcSEcCtD
Bicalutamide—Hypersensitivity—Topotecan—cervical cancer	0.00589	0.00728	CcSEcCtD
Bicalutamide—Asthenia—Topotecan—cervical cancer	0.00574	0.00709	CcSEcCtD
Bicalutamide—CYP2C9—female reproductive system—cervical cancer	0.00573	0.0301	CbGeAlD
Bicalutamide—Pruritus—Topotecan—cervical cancer	0.00566	0.00699	CcSEcCtD
Bicalutamide—Diarrhoea—Topotecan—cervical cancer	0.00547	0.00676	CcSEcCtD
Bicalutamide—CYP3A4—renal system—cervical cancer	0.00546	0.0286	CbGeAlD
Bicalutamide—CYP2D6—renal system—cervical cancer	0.00537	0.0282	CbGeAlD
Bicalutamide—Dizziness—Topotecan—cervical cancer	0.00529	0.00654	CcSEcCtD
Bicalutamide—Vomiting—Topotecan—cervical cancer	0.00509	0.00628	CcSEcCtD
Bicalutamide—Rash—Topotecan—cervical cancer	0.00504	0.00623	CcSEcCtD
Bicalutamide—Dermatitis—Topotecan—cervical cancer	0.00504	0.00623	CcSEcCtD
Bicalutamide—Headache—Topotecan—cervical cancer	0.00501	0.00619	CcSEcCtD
Bicalutamide—Nausea—Topotecan—cervical cancer	0.00475	0.00587	CcSEcCtD
Bicalutamide—AR—lymph node—cervical cancer	0.00467	0.0245	CbGeAlD
Bicalutamide—CYP3A4—female reproductive system—cervical cancer	0.00437	0.0229	CbGeAlD
Bicalutamide—CYP2D6—female reproductive system—cervical cancer	0.0043	0.0226	CbGeAlD
Bicalutamide—CYP2D6—female gonad—cervical cancer	0.00391	0.0205	CbGeAlD
